LexaGene (CVE:LXG) Stock Price Down 19.2% – Here’s What Happened

LexaGene Holdings Inc. (CVE:LXG)’s share price was down 19.2% on Friday . The company traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares were traded during trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.

LexaGene Trading Down 19.2 %

The firm has a market cap of C$14.77 million, a P/E ratio of -1.31 and a beta of 2.26. The firm has a fifty day moving average of C$0.11 and a 200-day moving average of C$0.11. The company has a debt-to-equity ratio of 138.01, a quick ratio of 1.13 and a current ratio of 1.39.

LexaGene Company Profile

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.